IRIS
PRADA, VALERIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.394
Totale 2.394
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.394
Totale 2.394
Salva come PNG Salva come JPEG
Città #
Genova 1.652
Rapallo 430
Genoa 299
Bordighera 13
Totale 2.394
Salva come PNG Salva come JPEG
Nome #
Sural nerve biopsy and functional studies support the pathogenic role of a novel MPZ mutation. 131
Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study 118
Hyccin, the Molecule Mutated in the Leukodystrophy Hypomyelination and Congenital Cataract (HCC), Is a Neuronal Protein. 117
Gain of glycosylation: a new pathomechanism of Myelin Protein Zero mutations 113
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy 113
Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype 108
A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy 107
Sacral Nerve Stimulation for Fecal Incontinence in a Patient with Antiphospholipid Syndrome- Related Autonomic Neuropathy 107
Immunohistochemical evidnce of HLA-G expression in extravillous trophoblast invading decidual tissues. 100
Testing overwork weakness in Charcot-Marie-tooth disease: Is it true or false? 100
Outcome measures in the clinical evaluation of ambulatory Charcot Marie Tooth 1A subjects 99
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 98
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. 80
Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017 75
The diadenosine homodinucleotide P18 improvesin vitromyelination in experimental Charcot-Marie-Tooth type 1A 71
GAIN OR LOSS OF GLYCOSYLATION: THE SWEET SIDE OF MYELIN PROTEIN ZERO 70
Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study 69
Treadmill training in patients affected by Charcot-Marie-Tooth neuropathy: results of a multicenter, prospective, randomized, single-blind, controlled study 68
People with Charcot-Marie-Tooth disease and COVID-19: Impaired physical conditions due to the lockdown. An International cross-sectional survey 58
Early detection of external neurological symptoms through a wearable smart-glasses prototype 58
P2X7 RECEPTOR IMPLICATION IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 56
EARLY ONSET DEMYELINATING CHARCOT‐MARIE‐TOOTH DISEASE CAUSED BY A NOVEL IN‐FRAME ISOLEUCINE DELETION IN PERIPHERAL MYELIN PROTEIN 2 55
Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years 53
P2X7 TARGETING IMPROVES IN VITRO MYELINATION IN EXPERIMENTAL CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 52
Comparison of Strength and Dexterity in Professional and Student Violinists: Setting Foundations to Guide Rehabilitation 52
Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years 50
A morphological reappraisal of Tubifex blanchardi Vejdovský, 1891 (Clitellata: Tubificidae) 49
Validation of a new hand function outcome measure in individuals with Charcot-Marie-Tooth disease 42
High-dose immunoglobulin pulse therapy and risk of Covid19 infection 40
Validation of the Italian version of the Charcot-Marie-Tooth disease Pediatric Scale 35
The suspected SARS-Cov-2 infection in a Charcot-Marie-Tooth patient undergoing postsurgical rehabilitation: the value of telerehabilitation for evaluation and continuing treatment 34
NeuroGlasses: A Wearable Prototype for Early Detection of Neurological Symptoms 34
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment 32
Charcot-Marie-Tooth neuropathy score and ambulation index are both predictors of orthotic need for patients with CMT 23
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism 19
OUTCOMES AFTER SINGLE-CYCLE RITUXIMAB MONOTHERAPY IN PATIENTS WITH ANTI-MAG ANTIBODY POLYNEUROPATHY: A 11 YEARS FOLLOW-UP ANALYSIS 1
Totale 2.487
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.100
article - articoli 8.433
book - libri 0
conference - conferenze 667
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201976 0 0 0 0 0 0 0 0 0 0 38 38
2019/2020680 21 12 18 48 60 83 103 60 76 105 63 31
2020/2021324 14 20 7 50 19 22 50 34 27 34 22 25
2021/2022379 15 22 22 32 16 29 15 84 26 49 15 54
2022/2023508 36 51 2 54 86 64 1 51 75 4 69 15
2023/2024242 18 23 7 46 20 63 21 21 18 5 0 0
Totale 2.487